Skip to main content
. Author manuscript; available in PMC: 2019 Sep 17.
Published in final edited form as: Drug Dev Res. 2018 Sep 17;79(6):287–294. doi: 10.1002/ddr.21441

Figure 3.

Figure 3

Live-Dead FDA-PI assay in Panc-1 cells 48h post drug treatment was determined by flow cytometry. Treatment concentrations were chosen based on the respective GI50 values of DMAPT and ActD, and maintaining a constant ratio for the drug combination concentrations. Live and dead cell populations were detected by incubating Panc-1 cells with FDA at 37°C and PI at room temperature, respectively, in CO2-independent media.

(*p<0.05 vs each individual drug)